INTERACTION OF SECRETIN-5-27 AND ITS ANALOGS WITH HORMONE RECEPTORS ON PANCREATIC ACINI

被引:84
作者
GARDNER, JD
ROTTMAN, AJ
NATARAJAN, S
BODANSZKY, M
机构
[1] NIAMDD, DIGEST DIS BRANCH, GASTROENTEROL SECT, BETHESDA, MD 20014 USA
[2] CASE WESTERN RESERVE UNIV, DEPT CHEM, CLEVELAND, OH 44106 USA
关键词
(Pancreatic acini); Receptor; Secretin; Vasoactive intestinal peptide;
D O I
10.1016/0304-4165(79)90066-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The C-terminal tricosapeptide of secretin (S5-27) and 2 analogs, one with Asn replacing Asp in position 15 (15-Asn-S5-27) and one with Lys replacing Asp in position 15 (15-Lys-S5-27) were tested for their abilities to interact with hormone receptors on [guinea pig] pancreatic acinar cells. In interacting with the receptors which prefer vasoactive intestinal peptide (VIP-preferring receptors), the apparent affinity of 15-Asn-S5-27 was equal to that of 15-Lys-S5-27 and was greater than that of S5-27. In interacting with secretin-preferring receptors, the apparent affinity of 15-Asn-S5-27 was equal to that of S5-27 and was greater than that of 15-Lys-S5-27. In interacting with the secretin-preferring receptors each of the secretin fragments was approximately 2% as effective as secretin in causing an increase in cellular cyclic[c]AMP. None of these fragments was able to cause a detectable increase in cAMP mediated by the VIP-preferring receptors. The dose vs. response curves for the action of secretin and vasoactive intestinal peptide on cellular cAMP and on amylase secretion as well as the pattern of effects of secretin fragments on these actions indicated that the increase in amylase secretion caused by VIP and secretin is mediated exclusively by the VIP-preferring receptors. Occupation of approximately 50% of the VIP-preferring receptors is sufficient to cause maximal stimulation of amylase secretion.
引用
收藏
页码:491 / 503
页数:13
相关论文
共 14 条
[1]   SYNTHESIS AND SOME PHARMACOLOGICAL PROPERTIES OF 23-PEPTIDE 15-LYSINE-SECRETIN-(5-27) - SPECIAL ROLE OF RESIDUE IN POSITION-15 IN BIOLOGICAL-ACTIVITY OF VASOACTIVE INTESTINAL POLYPEPTIDE [J].
BODANSZKY, M ;
NATARAJAN, S ;
GARDNER, JD ;
MAKHLOUF, GM ;
SAID, SI .
JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (11) :1171-1173
[2]   RE-EXAMINATION OF CONFORMATION OF SECRETIN IN WATER [J].
BODANSZKY, M ;
FINK, ML ;
FUNK, KW ;
SAID, SI .
CLINICAL ENDOCRINOLOGY, 1976, 5 :S195-S200
[3]   RANGES OF ALPHA-AMYLASE ACTIVITIES IN HUMAN SERUM AND URINE AND CORRELATIONS WITH SOME OTHER ALPHA-AMYLASE METHODS [J].
CESKA, M ;
BROWN, B ;
BIRATH, K .
CLINICA CHIMICA ACTA, 1969, 26 (03) :445-&
[4]   A NEW AND RAPID METHOD FOR CLINICAL DETERMINATION OF ALPHA-AMYLASE ACTIVITIES IN HUMAN SERUM AND URINE . OPTIMAL CONDITIONS [J].
CESKA, M ;
BIRATH, K ;
BROWN, B .
CLINICA CHIMICA ACTA, 1969, 26 (03) :437-&
[5]  
CHRISTOPHE JP, 1976, J BIOL CHEM, V251, P4629
[6]  
DESCHODTLANCKMAN M, 1975, GASTROENTEROLOGY, V68, P318
[7]   SECRETIN .6. SIMULTANEOUS INSITU SYNTHESES OF 3 ANALOGS OF C-TERMINAL TRICOSAPEPTIDE AND A STUDY OF THEIR CONFORMATION [J].
FINK, ML ;
BODANSZKY, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1976, 98 (04) :974-977
[8]  
GARDNER JD, 1976, GASTROENTEROLOGY, V71, P965
[9]  
GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52
[10]   REGULATION OF AMYLASE RELEASE FROM DISPERSED PANCREATIC ACINAR CELLS [J].
GARDNER, JD ;
JACKSON, MJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1977, 270 (02) :439-454